PMID- 7943405 OWN - NLM STAT- MEDLINE DCOM- 19941118 LR - 20171213 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 267 IP - 4 Pt 2 DP - 1994 Oct TI - Mechanisms mediating responsiveness to beta-adrenergic stimulation after coronary reperfusion in conscious dogs. PG - H1578-88 AB - The goal of this study was to assess beta-adrenergic receptor (beta-AR) signaling mechanisms in mediating physiological responses to sympathomimetic amines after 45 min coronary artery occlusion followed by 45 min reperfusion. At this time, isoproterenol (Iso) infusion (0.1 microgram/kg-1.min-1, n = 5) increased percent wall thickening in previously ischemic subendocardium (Endo) more than in nonischemic Endo (12.6 +/- 1.2 vs. 7.2 +/- 0.6%, P < 0.05), whereas forskolin (25 nmol.kg-1.min-1, n = 6) elicited the opposite effect (3.6 +/- 0.6 vs. 10.4 +/- 2.8%, P < 0.05). During Iso and forskolin infusions increases in regional myocardial blood flow in the previously ischemic zone were similar to the nonischemic zone. In all groups, total beta-AR density was depressed in previously ischemic Endo compared with nonischemic Endo (65 +/- 7 vs. 82 +/- 8 fmol/mg, P < 0.05), but the fraction of beta-AR binding agonist with high affinity increased (82 +/- 4 vs. 49 +/- 1%, P < 0.05). The changes in beta-AR were associated with a decrease in Iso-stimulated adenylyl cyclase (22 +/- 8%), a decrease in guanosine 5'-triphosphate (GTP)-stimulatory protein (Gs) (23 +/- 6%), and a decrease in inhibitory G proteins (16 +/- 4%). However, regional Endo functional responsiveness to beta-AR stimulation was enhanced in reperfused myocardium in response to Iso but not to forskolin. Thus the mechanism of increased number of beta-AR binding agonist with high affinity in previously ischemic myocardium predominated over persistent downregulation of total beta-AR density and reductions in Gs and adenylyl cyclase activity and correlated best with the physiological response to beta-AR stimulation. These data may also suggest that Iso exerts an action distal to adenylyl cyclase in previously ischemic myocardium. FAU - Kiuchi, K AU - Kiuchi K AD - Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston 02115. FAU - Shen, Y T AU - Shen YT FAU - Vatner, S F AU - Vatner SF FAU - Vatner, D E AU - Vatner DE LA - eng GR - HL-33065/HL/NHLBI NIH HHS/United States GR - HL-37404/HL/NHLBI NIH HHS/United States GR - HL-45332/HL/NHLBI NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Peptide Fragments) RN - 0 (Receptors, Adrenergic, beta) RN - 1F7A44V6OU (Colforsin) RN - EC 3.6.1.- (GTP-Binding Proteins) RN - L628TT009W (Isoproterenol) SB - IM MH - Amino Acid Sequence MH - Animals MH - Blood Pressure/drug effects MH - Colforsin/pharmacology MH - Coronary Vessels/*physiology MH - Dogs MH - Electrophoresis, Polyacrylamide Gel MH - Female MH - GTP-Binding Proteins/analysis/*biosynthesis MH - Heart/drug effects/physiology/*physiopathology MH - Heart Rate/drug effects MH - Hemodynamics/*drug effects/physiology MH - Isoproterenol/*pharmacology MH - Male MH - Molecular Sequence Data MH - Myocardial Ischemia/*physiopathology MH - *Myocardial Reperfusion MH - Myocardium/metabolism MH - Peptide Fragments/immunology MH - Receptors, Adrenergic, beta/*physiology MH - Signal Transduction MH - Time Factors MH - Ventricular Function, Left/drug effects/physiology EDAT- 1994/10/01 00:00 MHDA- 1994/10/01 00:01 CRDT- 1994/10/01 00:00 PHST- 1994/10/01 00:00 [pubmed] PHST- 1994/10/01 00:01 [medline] PHST- 1994/10/01 00:00 [entrez] AID - 10.1152/ajpheart.1994.267.4.H1578 [doi] PST - ppublish SO - Am J Physiol. 1994 Oct;267(4 Pt 2):H1578-88. doi: 10.1152/ajpheart.1994.267.4.H1578.